Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 15, 2019

Study Completion Date

January 30, 2020

Conditions
Chronic Kidney Disease Requiring Chronic Dialysis
Interventions
DRUG

Propolis Period (Green Propolis 250mg/day)

Randomized, cross-over, open-label. Patients will go through two 4 week periods with 1 week washout between them. During the intervention period will use 250mg of green Propolis per day. In the control period they will only follow standard treatment for their comorbidities.

OTHER

Control Period

In the control period they will only follow standard treatment for their comorbidities.

Trial Locations (1)

41820-340

Marcelo Augusto Duarte Silveira, Salvador

All Listed Sponsors
collaborator

Hospital Sao Rafael

OTHER

collaborator

Alagoas State University of Health Science , Maceió , Brazil.

UNKNOWN

lead

University of Sao Paulo General Hospital

OTHER

NCT04072341 - Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients. | Biotech Hunter | Biotech Hunter